SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-100414
Filing Date
2021-08-05
Accepted
2021-08-05 07:10:51
Documents
48
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcli-20210630x10q.htm   iXBRL 10-Q 1015533
2 EXHIBIT 31.1 bcli-20210630xex31d1.htm EX-31.1 11023
3 EXHIBIT 31.2 bcli-20210630xex31d2.htm EX-31.2 11034
4 EXHIBIT 32.1 bcli-20210630xex32d1.htm EX-32.1 6855
5 EXHIBIT 32.2 bcli-20210630xex32d2.htm EX-32.2 6165
  Complete submission text file 0001104659-21-100414.txt   3281371

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcli-20210630.xsd EX-101.SCH 25107
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20210630_cal.xml EX-101.CAL 22994
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20210630_def.xml EX-101.DEF 63274
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20210630_lab.xml EX-101.LAB 196464
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20210630_pre.xml EX-101.PRE 161183
11 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20210630x10q_htm.xml XML 405210
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 211146274
SIC: 2836 Biological Products, (No Diagnostic Substances)